Showing results (21-30 of 56) with videos related to
Sort By:
Pageof 6
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 8, 2024
Evaluating Policies of Expanding Versus Restricting First-Line Treatment Choices: A Cost-Effectiveness Analysis FrameworkBoshen Jiao, Josh J Carlson, Louis P Garrison, et al.International Journal of Environmental Research and Public Health|August 17, 2018
The Trade-Off between Optimizing Flight Patterns and Human Health: A Case Study of Aircraft Noise in Queens, NY, USAZafar Zafari, Boshen Jiao, Brian Will, et al.Plos One|December 12, 2018
The cost-effectiveness analysis of the New Rural Cooperative Medical Scheme in ChinaJinjing Wu, Shelby Deaton, Boshen Jiao, et al.International Journal of Environmental Research and Public Health|December 7, 2017
The Cost-Effectiveness of Lowering Permissible Noise Levels Around U.S. AirportsBoshen Jiao, Zafar Zafari, Brian Will, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 22, 2021
A Quantitative Framework to Study Potential Benefits and Harms of Multi-Cancer Early Detection TestingBoshen Jiao, Roman Gulati, Hormuzd A Katki, et al.Emerging Themes in Epidemiology|November 29, 2016
Nutrition surveillance using a small open cohort: experience from Burkina FasoMathias Altmann, Christophe Fermanian, Boshen Jiao, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 18, 2026
Incorporating equity and financial protection criteria into essential benefits package design: a case study of infectious diseases interventions in EthiopiaLelisa Fekadu Assebe, Boshen Jiao, Nathaniel Hendrix, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 8, 2025
Incorporating Informal Caregiving Time Into Cost-Effectiveness Analysis for Adults Aged 50 and Older: Estimating From Health-Related Quality of Life and Functional StatusBoshen Jiao, Xinran Lu, Darius N Lakdawalla, et al.Journal of Managed Care & Specialty Pharmacy|November 30, 2020
The use of real-world evidence in ICER's scoping process and clinical evidence assessmentsBoshen Jiao, David L Veenstra, Woojung Lee, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 14, 2022
Does Clinical Evidence of Heterogeneity Impact Treatment Selection? A Case Study of Abiraterone for Metastatic Prostate CancerBoshen Jiao, Yaw A Nyame, Josh J Carlson, et al.Pageof 6